BSX vs GMED
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 03, 2026
BSX
GMED
Investment Advisor Scores
GMED
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BSX | GMED | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 13.2275 | 13.8696 | BSX |
| PEG Ratio | 0.6251 | 1.7253 | BSX |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 7.5% | 5.9% | BSX |
| Earnings Growth | 15.1% | -26.2% | BSX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 62.4/100 | 53.9/100 | BSX |
| Profit Margin | 17.5% | 17.0% | BSX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BSX
NeutralMixed signals - no dominant trend phase, RSI 36
GMED
NeutralMixed signals - no dominant trend phase, RSI 46
Fundamentals Snapshot
| Metric | BSX | GMED |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 12.5 | 14.0 |
| Trailing P/E | 17.6 | 19.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.7% | 0.7% |
| Operating Margin | 0.2% | 0.2% |
| EPS | 2.45 | 3.88 |
| Dividend Yield | — | — |